Peptic ulcer disease: Clinical sciences

Last updated: January 30, 2025

Peptic ulcer disease: Clinical sciences

Beta Clinical Sciences Videos

Beta Clinical Sciences Videos

Approach to biliary colic: Clinical sciences
Approach to periumbilical and lower abdominal pain: Clinical sciences
Approach to pneumoperitoneum and peritonitis (perforated viscus): Clinical sciences
Approach to postoperative abdominal pain: Clinical sciences
Approach to upper abdominal pain: Clinical sciences
Abdominal aortic aneurysm: Clinical sciences
Acute mesenteric ischemia: Clinical sciences
Alcohol-induced hepatitis: Clinical sciences
Approach to ascites: Clinical sciences
Cholecystitis: Clinical sciences
Choledocholithiasis and cholangitis: Clinical sciences
Chronic pancreatitis: Clinical sciences
Diverticulitis: Clinical sciences
Gastroesophageal reflux disease: Clinical sciences
Hepatitis C: Clinical sciences
Ileus: Clinical sciences
Inflammatory bowel disease (Crohn disease): Clinical sciences
Inflammatory bowel disease (ulcerative colitis): Clinical sciences
Intra-abdominal abscess: Clinical sciences
Ischemic colitis: Clinical sciences
Large bowel obstruction: Clinical sciences
Lower urinary tract infection: Clinical sciences
Peptic ulcer disease: Clinical sciences
Pyelonephritis: Clinical sciences
Rectus sheath hematoma: Clinical sciences
Retroperitoneal hematoma: Clinical sciences
Small bowel obstruction: Clinical sciences
Acute coronary syndrome: Clinical sciences
Approach to tachycardia: Clinical sciences
Aspiration pneumonia and pneumonitis: Clinical sciences
Community-acquired pneumonia: Clinical sciences
Coronary artery disease: Clinical sciences
Hospital-acquired and ventilator-associated pneumonia: Clinical sciences
Pneumothorax: Clinical sciences
Pulmonary embolism: Clinical sciences
Ventricular tachycardia: Clinical sciences
Anaphylaxis: Clinical sciences
Approach to bradycardia: Clinical sciences
Asthma: Clinical sciences
Atelectasis: Clinical sciences
Cardiac tamponade: Clinical sciences
Chronic obstructive pulmonary disease: Clinical sciences
Congestive heart failure: Clinical sciences
Opioid intoxication and overdose: Clinical sciences
Cirrhosis: Clinical sciences
Approach to lower limb edema: Clinical sciences
Deep vein thrombosis: Clinical sciences
Approach to hematochezia: Clinical sciences
Anal fissure: Clinical sciences
Hemorrhoids: Clinical sciences
Approach to melena and hematemesis: Clinical sciences
Gastroesophageal varices: Clinical sciences
Stress ulcers: Clinical sciences
Approach to nosocomial infections: Clinical sciences
Catheter-associated urinary tract infection: Clinical sciences
Central line-associated bloodstream infection: Clinical sciences
Clostridioides difficile infection: Clinical sciences
Pressure-induced skin and soft tissue injury: Clinical sciences
Surgical site infection: Clinical sciences
Diabetes mellitus (Type 2): Clinical sciences
Dyslipidemia: Clinical sciences
Essential hypertension: Clinical sciences
Obesity and metabolic syndrome: Clinical sciences
Appendicitis: Clinical sciences
Approach to chest pain: Clinical sciences
Approach to dyspnea: Clinical sciences
Approach to jaundice (conjugated hyperbilirubinemia): Clinical sciences
Approach to jaundice (unconjugated hyperbilirubinemia): Clinical sciences
Pancreatic cancer: Clinical sciences
Approach to a postoperative fever: Clinical sciences
Approach to postoperative wound complications: Clinical sciences
Delirium: Clinical sciences
Malignant hyperthermia: Clinical sciences
Medication-induced constipation: Clinical sciences
Approach to shock: Clinical sciences
Multiple organ dysfunction syndrome (MODS): Clinical sciences
Sepsis: Clinical sciences
Hypovolemic shock: Clinical sciences
Burns: Clinical sciences
Infectious gastroenteritis: Clinical sciences

Decision-Making Tree

Transcript

Watch video only

Peptic Ulcer Disease, or PUD for short, is a condition characterized by ulcers in areas exposed to excess gastric acid and peptic juices. So, peptic ulcers can be located in the stomach, typically on the lesser curvature, which are referred to as gastric ulcers; or in the duodenum, usually in the duodenal bulb, which are referred to as duodenal ulcers.

There are two main causes of PUD - Helicobacter Pylori, or H. Pylori infections, and Non-Steroidal Anti Inflammatory Drugs, or NSAIDs. PUD can result in complications, such as bleeding, perforation, and malignancy.

Now, when assessing a patient with suspected PUD, the first thing you should do is an ABCDE assessment, to determine if your patient is unstable or stable. In unstable individuals, history might reveal alarm symptoms such as melena, severe hematochezia, or large-volume hematemesis, indicating a GI bleed. They may also report persistent severe epigastric pain. Additionally, physical exam findings can include orthostatic hypotension, tachycardia, pallor, and epigastric tenderness to palpation, suggesting a possible active GI bleed or even perforation.

A high yield fact to remember is if your patient with suspected PUD also reports unintentional weight loss, be on the lookout for malignancies!

Now for unstable patients, the goal is to immediately stabilize them. You might need to place two large bore IVs, initiate cardiac monitoring, start IV fluid resuscitation and transfuse blood products.

After you’ve stabilized the patient, you should determine the cause of the instability. The peptic ulcer itself can be causing a severe GI bleed or worse yet, it may have perforated. But, to confirm any of these diagnoses, first you need to order a diagnostic Esophagogastroduodenoscopy, or EGD with biopsies. Order iron studies and monitor the patient with serial CBCs. Consider a surgical consultation if there’s a perforation.

Alright, moving on to treatment. If a bleeding ulcer is suspected, you should start antisecretory therapy via IV Proton Pump Inhibitor, or PPI.

The bleeding should be stopped during endoscopy. If you are unable to stop the bleeding endoscopically, you should consult the surgical team. On the flip side, if you suspect an underlying malignancy, you might obtain an oncology consultation.

Once you stop the bleeding, the next step is to give high-dose PPI for 3 days before assessing the need for ongoing acid suppression with long-term antisecretory therapy.

Indications for continued acid suppression include a persistent ulcer on repeat EGD; a giant ulcer greater than 2 cm in a patient over the age of 50; and a history of recurrent ulcers, or more than 2 ulcers in a year. Additionally, you should continue acid suppression if a patient is on long-term NSAID therapy.

So, if you find any of these, initiate long-term antisecretory therapy with oral PPIs and advise lifestyle changes like avoiding alcohol and smoking cessation.

On the other hand, if none of these criteria areis met, there’s no need for further treatment, unless symptoms recur.

Ok, now that we’re done with the treatment for unstable patients, let’s take a look at stable patients. In history, these patients typically report epigastric abdominal pain, bloating, and nausea. They may also have a history of NSAID and corticosteroid use, H.Pylori infection, or previous ulcers. On physical exam, you will usually encounter tenderness to palpation in the epigastrium.

Now, if you suspect PUD based on the patient’s history and physical exam findings, move on to H. Pylori testing. The method of testing depends on the patient’s age. If the patient is less than 60 years old, test for H.pylori with a urea breath test or stool antigen. On the other hand, if the patient is 60 years or older, proceed with an EGD and biopsy. This is a high yield fact, because the risk for malignancy increases as patients age!

Sources

  1. "ACG Clinical Guideline: Upper Gastrointestinal and Ulcer Bleeding" Am J Gastroenterol (2021)
  2. "AGA Clinical Practice Update on Endoscopic Therapies for Non-Variceal Upper Gastrointestinal Bleeding: Expert Review" Gastroenterology (2020)
  3. "Eradication therapy in Helicobacter pylori positive peptic ulcer disease: systematic review and economic analysis" Am J Gastroenterol (2020)
  4. "Association between clinical manifestations of complicated and uncomplicated peptic ulcer and visceral sensory dysfunction" J Gastroenterol Hepatol (2020)
  5. "The prevalence of Helicobacter pylori in peptic ulcer disease" Aliment Pharmacol Ther (1995)
  6. "Features associated with painless peptic ulcer bleeding" Am J Gastroenterol (1997)